BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35599725)

  • 1. Antibiotic susceptibility patterns of viridans group streptococci isolates in the United States from 2010 to 2020.
    Singh N; Poggensee L; Huang Y; Evans CT; Suda KJ; Bulman ZP
    JAC Antimicrob Resist; 2022 Jun; 4(3):dlac049. PubMed ID: 35599725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial susceptibility of Viridians Group of Streptococci isolated from infective endocarditis patients from 2018 to 2023.
    Jagadeesan N; Karur K; Nandini MP; Manjunath CN; Prapulla Kumari N; Praveen Kumar HD
    Indian J Med Microbiol; 2024; 49():100576. PubMed ID: 38556250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythromycin and penicillin resistance mechanisms among viridans group streptococci isolated from blood cultures of adult patients with underlying diseases.
    Ergin A; Eser ÖK; Hasçelik G
    New Microbiol; 2011 Apr; 34(2):187-93. PubMed ID: 21617831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Species designation of streptococci causing infective endocarditis in patients with mitral valve prolapse.
    Quintero-Martinez JA; Hindy JR; Zein SE; Vikram HR; Bosch W; DeSimone DC; Baddour LM
    Int J Infect Dis; 2023 Jun; 131():71-74. PubMed ID: 36967036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence rate and antibiotic susceptibility of oral viridans group streptococci (VGS) in healthy children population.
    Rozkiewicz D; Daniluk T; Sciepuk M; Zaremba ML; Cylwik-Rokicka D; Luczaj-Cepowicz E; Milewska R; Marczuk-Kolada G; Stokowska W
    Adv Med Sci; 2006; 51 Suppl 1():191-5. PubMed ID: 17460837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population structure and characterization of viridans group streptococci (VGS) isolated from the upper respiratory tract of patients in the community.
    Nakajima T; Nakanishi S; Mason C; Montgomery J; Leggett P; Matsuda M; Coulter WA; Millar BC; Goldsmith CE; Moore JE
    Ulster Med J; 2013 Sep; 82(3):164-8. PubMed ID: 24505152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population structure and characterization of viridans group streptococci (VGS) including Streptococcus pneumoniae isolated from adult patients with cystic fibrosis (CF).
    Maeda Y; Elborn JS; Parkins MD; Reihill J; Goldsmith CE; Coulter WA; Mason C; Millar BC; Dooley JS; Lowery CJ; Ennis M; Rendall JC; Moore JE
    J Cyst Fibros; 2011 Mar; 10(2):133-9. PubMed ID: 21145793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Identification and antibiotic susceptibility of viridans group streptococci isolates recovered from patients hospitalized at a teaching hospital in Buenos Aires City].
    Heine AC; García S; Barberis C; Vay C; E Mollerach M; Bonofiglio L; Famiglietti Á
    Rev Argent Microbiol; 2019; 51(1):26-31. PubMed ID: 29941157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Species-specific difference in antimicrobial susceptibility among viridans group streptococci.
    Chun S; Huh HJ; Lee NY
    Ann Lab Med; 2015 Mar; 35(2):205-11. PubMed ID: 25729722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Genomics of Streptococcus oralis Identifies Large Scale Homologous Recombination and a Genetic Variant Associated with Infection.
    Joyce LR; Youngblom MA; Cormaty H; Gartstein E; Barber KE; Akins RL; Pepperell CS; Palmer KL
    mSphere; 2022 Dec; 7(6):e0050922. PubMed ID: 36321824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility of viridans group streptococcal blood isolates to eight antimicrobial agents.
    Smith A; Jackson MS; Kennedy H
    Scand J Infect Dis; 2004; 36(4):259-63. PubMed ID: 15198181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF).
    Tazumi A; Maeda Y; Goldsmith CE; Coulter WA; Mason C; Millar BC; McCalmont M; Rendall J; Elborn JS; Matsuda M; Moore JE
    J Antimicrob Chemother; 2009 Sep; 64(3):501-6. PubMed ID: 19584106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci.
    Entenza JM; Vouillamoz J; Glauser MP; Moreillon P
    Antimicrob Agents Chemother; 2004 Jan; 48(1):86-92. PubMed ID: 14693523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Classical and new approaches in laboratory diagnosis of viridans streptococci].
    Ergin A
    Mikrobiyol Bul; 2010 Jul; 44(3):495-503. PubMed ID: 21064001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibiotic resistance analysis of
    Ge LL; Han ZY; Liu AH; Zhu L; Meng JH
    Zhonghua Er Ke Za Zhi; 2017 Feb; 55(2):109-114. PubMed ID: 28173648
    [No Abstract]   [Full Text] [Related]  

  • 16. Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic viridans group streptococci in a tertiary Korean hospital.
    Uh Y; Hwang GY; Jang IH; Kwon O; Kim HY; Yoon KJ
    J Korean Med Sci; 2007 Oct; 22(5):791-4. PubMed ID: 17982224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daptomycin Dose-Ranging Evaluation with Single-Dose versus Multidose Ceftriaxone Combinations against Streptococcus mitis
    Kebriaei R; Rice SA; Stamper KC; Seepersaud R; Garcia-de-la-Maria C; Mishra NN; Miro JM; Arias CA; Tran TT; Sullam PM; Bayer AS; Rybak MJ
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility of viridans group streptococci in Taiwan with an emphasis on the high rates of resistance to penicillin and macrolides in Streptococcus oralis.
    Teng LJ; Hsueh PR; Chen YC; Ho SW; Luh KT
    J Antimicrob Chemother; 1998 Jun; 41(6):621-7. PubMed ID: 9687100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and microbiological profile of Viridans group streptococcal bacteraemia; experience from South India.
    Arjun R; Niyas VKM; Hussain F; Surendran S; Mohan V
    Infez Med; 2024; 32(1):37-44. PubMed ID: 38456022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nosocomial streptococcal blood stream infections in the SCOPE Program: species occurrence and antimicrobial resistance. The SCOPE Hospital Study Group.
    Pfaller MA; Jones RN; Marshall SA; Edmond MB; Wenzel RP
    Diagn Microbiol Infect Dis; 1997 Dec; 29(4):259-63. PubMed ID: 9458983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.